77
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editors

Characteristics of Persistent Hyponatremia and Tolvaptan Treatment in Nine Hospitalized Patients With Advanced HIV Disease

, , , , , & show all
Pages 126-132 | Published online: 22 Dec 2014

REFERENCES

  • Marco Martinez J. Hyponatremia: Classification and dif-ferential diagnosis. Endocrinol Nutr. 2010;57(Suppl 2):2–9.
  • Waikar SS, Mount DB, Curhan GC. Mortality after hospital-ization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122(9):857–865.
  • Bennani SL, Aboucial R, Zeggwagh AA, et al. Incidence, causes and prognostic factors of hyponatremia in inten-sive care. Rev Med Interne. 2003;24(4):224–229.
  • Tang WW, Kaptein EM, Feinstein El, Massry SG. Hypona-tremia in hospitalized patients with the acquired immuno-deficiency syndrome (AIDS) and the AIDS-related com-plex. Am J Med. 1993;94(2):169–174.
  • Dao CN, Peters PJ, Kiarie JN, et al. Hyponatremia, hypo-chloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women. AIDS Res Hum Retro viruses. 201127(11):1149–1155.
  • Menon MC, Garcha AS, Khanna A. The management of hyponatremia in HIV disease. J Nephrol. 2013;26(1):61–72.
  • Friedman B, Cirulli J. Hyponatremia in critical care patients: Frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan. J Crit Care. 2013;28(2):219.e1-12.
  • Gheorghiade M, Rossi JS, Cotts W, et al. Characteriza-tion and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med. 2007;167(18):1998–2005.
  • Vitting KE, Gardenswartz MH, Zabetakis PM, et al. Fre-quency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome. JAMA. 1990;263(7):973–978.
  • Elhassan EA, Schrier RW. The use of vasopressin receptor antagonists in hyponatremia. Expert Opin Investig Drugs. 2011;20(3):373–80.
  • UK Collaborative HIV Cohort (UK CHIC) Steering Com-mittee, Sabin CA, Schwenk A, et al. Late diagnosis in the HAART era: Proposed common definitions and associa-tions with mortality. AIDS. 2010; 24(5):723–727.
  • World Health Organization. Antiretroviral Therapy for HIV. Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision. Geneva: Author; 2010.
  • Berl T, Anderson RJ, McDonald KM, Schrier RW. Clinical dis-orders of water metabolism. Kidney Int. 1976;10(1):117–132.
  • Artom N, Oddo S, Pende A, et al. Syndrome of inappropri-ate antidiuretic hormone secretion and ibuprofen, a rare association to be considered: role of tolvaptan. Case Rep Endocrinol. 2013;2013:818259.
  • Lee P, Ho KK. Hyponatremia in pulmonary TB: Evidence of ectopic antidiuretic hormone production. Chest. 2010;137(1):207–208.
  • Jonaidi Jafari N, Izadi M, Sarrafzadeh F, et al. Hyponatre-mia due to pulmonary tuberculosis: Review of 200 cases. Nephrourol Mon. 2013;5(1):687–691.
  • Pedersen EB, Danielsen H, Madsen M, Jensen T. Defective renal water excretion in nephrotic syndrome: The relation-ship between renal water excretion and kidney function, arginine vasopressin, angiotensin ll and aldosterone in plasma before and after oral water loading. Eur J Clin Invest. 1985;15(1):24–29.
  • Roca B, Tornador N, Tornador E. Presentation and out-come of tuberculous meningitis in adults in the province of Castellon, Spain: A retrospective study. Epidemiol Infect. 2008;136(11):1455–1462.
  • Babayev R, Terner S, Chandra S, et al. Trimethoprim-asso-ciated hyponatremia. Am J Kidney Dis. 2013;62(6):1188–1192.
  • Cusano AJ, Thies HL, Siegal FP, et al. Hyponatremia in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr. 1990;3(10):949–953.
  • Robertson GL. Antidiuretic hormone - Normal and dis-ordered function. Endocrinol Metab Clin North Am. 2001;30(3):671–694.
  • Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med. 1987;83(5):905–908.
  • Chubb SA. Hyponatremia treatment guidelines 2007: Expert panel recommendations. Clin Biochem Rev. 2009;30(1):35–38.
  • Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355(20):2099–2112.
  • Bevilacqua M. Hyponatraemia in AIDS. Baillieres Clin Endocrinol Metab. 1994;8(4):837–848.
  • Agarwal A, Soni A, Ciechanowsky M, et al. Hyponatremia in patients with the acquired immunodeficiency syndrome. Nephron. 1989;53(4):317–321.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.